Victor Khabie, MD
Orthopedic Surgery · Carmel, NYNPI 1922029701
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $9,700 of the $15,038 with a category attached, or 64.5%. 13 manufacturers reported payments, led by Arthrex at 49.8% of the total. Reporting peaked in 2024 at $3,899 and has fallen 59.2% since, to $1,591 in 2025.
Across 132 payments — averaging $113.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$7K
- Stryker$3K
- Gotham Surgical Solutions & Devices, Inc.$2K
- Globus Medical$1K
- Hikma Pharmaceuticals USA$423
- Smith+Nephew$240
- plus $226 from 7 others
What the payments were for
- Consulting fees$4233%
- Travel & lodging$9,70065%
- Food & beverage$3,71525%
- Education$1,2008%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 86 | $7,483 |
| Stryker | 18 | $3,289 |
| Gotham Surgical Solutions & Devices, Inc. | 8 | $1,902 |
| Globus Medical | 2 | $1,475 |
| Hikma Pharmaceuticals USA | 1 | $423 |
| Smith+Nephew | 6 | $240 |
| Johnson & Johnson(2 entities) | 4 | $102 |
| Ferring Pharmaceuticals Inc. | 2 | $31 |
| DJO, LLC | 1 | $25 |
| Medical Device Business Services, Inc. | 1 | $23 |
| Convatec Inc. | 1 | $16 |
| Curonix LLC | 1 | $16 |
| Amgen | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$2,962
- Actify$704
- COMBOGESIC IV$423
- ACCOLADE$319
- TRIATHLON$171
How this compares
$15,038 in reported general payments places this provider in the 85th percentile of 91 orthopedic surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 27 | $86 |
Paid to pharmacies, not to this prescriber.
Other orthopedic surgery in Carmel
- Andrew PeretzCarmel$10K
- Jeffrey PassickCarmel$1K
- Stuart StylesCarmel$1K
- Douglas FauserCarmel$404
- Baron LonnerNew York$2.1M
- Jan KoenigRockville Centre$1.4M
- Lon WeinerNew York$622K
- Andrew CappuccinoLockport$581K
- Douglas PadgettUniondale$407K
- James GladstoneNew York$260K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.